Efficacy of S-1vscapecitabine for the treatment of gastric cancer: A meta-analysis-Reference-Cited by-同舟云学术

Efficacy of S-1vscapecitabine for the treatment of gastric cancer: A meta-analysis

Published:2015 Issue:14 Volume:21 Page:4358
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

He An-Bing

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference35 articles.

1. Global cancer statistics

2. Cancer statistics, 2012

3. Wu HL, Tian Q, Peng CW, Liu SP, Li Y. Multivariate survival and outcome analysis of 154 patients with gastric cancer at a single Chinese institution. Asian Pac J Cancer Prev 2011;12:3341-3345.

4. Gastric cancer

5. Chemotherapy for Advanced Gastric Cancer: Slow but Further Progress

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S-1 plus oxaloplatin (S-1OX) versus capecitabine plus oxaloplatin (CAPOX) for advanced gastric cancer: A systematic review and meta-analysis;Computer Methods and Programs in Biomedicine Update;2024

2. Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study;Gastric Cancer;2023-08-23

3. Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease;Cancers;2022-11-18

4. Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database;Therapeutic Advances in Drug Safety;2022-01

5. Comparison of S-1-based vs. capecitabine-based adjuvant chemotherapy for patients with gastric cancer: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2021-07-17